Pulmonary hypertension
RecruitingLong‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
Long‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
- Disease:Pulmonary hypertension
- Substances:Treprostinil Palmitil
Germany- Participants:18–64 years · 65+ years
- Substances:Treprostinil Palmitil
- Sponsor:Insmed Inc.











